C60519 |
Gene editing conversion blood CD3 plus lineage percent value |
Value of the percentage of gene-editing conversions in the blood CD3+ lineage.
|
Supplemental |
1.00 |
2021-04-23 11:20:12.0 |
Genotoxicity |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60522 |
Gene editing conversion blood GPA plus lineage percent value |
Value of the percentage of gene-editing conversions in the blood GPA+ lineage.
|
Core |
1.00 |
2021-04-23 11:20:12.0 |
Gene Product Follow-Up |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60522 |
Gene editing conversion blood GPA plus lineage percent value |
Value of the percentage of gene-editing conversions in the blood GPA+ lineage.
|
Supplemental |
1.00 |
2021-04-23 11:20:12.0 |
Genotoxicity |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60366 |
Blood pressure nocturnal diastolic elevated percent value |
Value of the percentage of nocturnal diastolic blood pressure measurements that were elevated.
|
Exploratory |
1.00 |
2021-03-31 13:02:49.0 |
Renal Function Assessments |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60365 |
Blood pressure nocturnal systolic elevated percent value |
Value of the percentage of nocturnal systolic blood pressure measurements that were elevated.
|
Exploratory |
1.00 |
2021-03-31 13:02:49.0 |
Renal Function Assessments |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60641 |
Gene editing site specific nuclease indel off target percent value |
Value of the percentage of off-target indels in blood for site-specific nuclease gene editing.
|
Core |
1.00 |
2021-04-30 11:24:37.0 |
Gene Product Follow-Up |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60640 |
Gene editing site specific nuclease indel on target percent value |
Value of the percentage of on-target indels in blood for site-specific nuclease gene editing.
|
Core |
1.00 |
2021-04-30 11:24:37.0 |
Gene Product Follow-Up |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60488 |
Peripheral blood mononuclear cell positive for integrating viral vector percent value |
Value of the percentage of peripheral blood mononuclear cells (PBMC) positive for the integrating viral vector.
|
Core |
1.00 |
2021-04-22 13:33:03.0 |
Gene Product Follow-Up |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60488 |
Peripheral blood mononuclear cell positive for integrating viral vector percent value |
Value of the percentage of peripheral blood mononuclear cells (PBMC) positive for the integrating viral vector.
|
Supplemental |
1.00 |
2021-04-22 13:33:03.0 |
Genotoxicity |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60630 |
Liver biopsy serum transferrin saturation percent value |
Value of the percentage of serum transferrin saturation detemined by laboratory anaylsis of liver biopsy sample.
|
Core |
1.00 |
2021-04-29 15:01:38.0 |
Iron Overload |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60608 |
Priapism erection percent value |
Value of the percentage of the subject/participant's penis that is erect.
|
Core |
1.00 |
2021-04-29 13:30:01.0 |
Priapism Core |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60355 |
Kidney MRI R2-star value |
Value of the R2* parameter for magnetic resonance imaging (MRI) of the kidney
|
Exploratory |
1.00 |
2021-03-31 12:34:05.0 |
Renal Function Assessments |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60370 |
Blood pressure diastolic daytime nocturnal measurement ratio value |
Value of the ratio of daytime and nocturnal diastolic blood pressure.
|
Exploratory |
1.00 |
2021-03-31 13:10:06.0 |
Renal Function Assessments |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60369 |
Blood pressure systolic daytime nocturnal measurement ratio value |
Value of the ratio of daytime and nocturnal systolic blood pressure.
|
Exploratory |
1.00 |
2021-03-31 13:10:06.0 |
Renal Function Assessments |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60356 |
Urine specific gravity value |
Value of the specific gravity of the subject/participant's urine.
|
Exploratory |
1.00 |
2021-03-31 12:37:24.0 |
Renal Function Assessments |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C59978 |
Immunoglobulin A before treatment value |
Value of the subject/participant's immunoglobulin A (IgA) measurement prior to any disease treatment.
|
Supplemental |
1.00 |
2020-09-01 15:47:39.0 |
Immune Function Form |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C59972 |
Immunoglobulin G before treatment value |
Value of the subject/participant's immunoglobulin G (IgG) measurement prior to any disease treatment.
|
Supplemental |
1.00 |
2020-09-01 15:47:39.0 |
Immune Function Form |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C59975 |
Immunoglobulin M before treatment value |
Value of the subject/participant's immunoglobulin M (IgM) measurement prior to any disease treatment.
|
Supplemental |
1.00 |
2020-09-01 15:47:39.0 |
Immune Function Form |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60232 |
Cardiac MRI left ventricle end-diastolic volume body surface area index value |
Value of the subject/participant's left ventricle end-diastolic volume (LVEDV), assessed by cardiac MRI, indexed to body surface area (BSA) in milliliters per square meter.
|
Core |
1.00 |
2021-03-02 13:43:54.0 |
Cardiac MRI |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60234 |
Cardiac MRI left ventricle end-systolic volume body surface area index value |
Value of the subject/participant's left ventricle end-systolic volume (LVESV), assessed by cardiac MRI, indexed to body surface area (BSA) in milliliters per square meter.
|
Core |
1.00 |
2021-03-02 13:43:54.0 |
Cardiac MRI |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60244 |
Cardiac MRI right ventricle end-diastolic volume body surface area index value |
Value of the subject/participant's right ventricle end-diastolic volume (RVEDV), assessed by cardiac MRI, indexed to body surface area (BSA) in milliliters per square meter.
|
Core |
1.00 |
2021-03-02 13:43:54.0 |
Cardiac MRI |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60246 |
Cardiac MRI right ventricle end-systolic volume body surface area index value |
Value of the subject/participant's right ventricle end-systolic volume (RVESV), assessed by cardiac MRI, indexed to body surface area (BSA) in milliliters per square meter.
|
Core |
1.00 |
2021-03-02 13:43:54.0 |
Cardiac MRI |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C08244 |
Imaging slice thickness value |
Value of the thickness of the slice measured in millimeters (mm)
|
Supplemental |
3.00 |
2013-07-25 08:54:08.2 |
Magnetic Resonance Angiography (MRA) |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C08244 |
Imaging slice thickness value |
Value of the thickness of the slice measured in millimeters (mm)
|
Supplemental |
3.00 |
2013-07-25 08:54:08.2 |
Miscellaneous Sickle Cell-related CDEs |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C08244 |
Imaging slice thickness value |
Value of the thickness of the slice measured in millimeters (mm)
|
Supplemental |
3.00 |
2013-07-25 08:54:08.2 |
PhenX CDEs |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|